arrow
H

Henry E. Mark

easl international liver foundation
H指数:18
被引数:2,141

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing Europe's policy readiness to confront the MASLD/MASH public health threat

评估欧洲应对MASLD/MASH公共卫生威胁的政策准备情况

2026-05-250
OAAI
Supplementary Material for Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data from Nine Countries

代谢功能障碍相关脂肪性肝炎(MASH)的全球临床、人文和经济影响预测项目补充资料:基于九国数据的无所作为的成本

2025-09-080
PRE
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis

代谢功能障碍相关脂肪性肝病和脂肪性肝炎的全球共识建议

2025-04-110
OAAI
Political courage needed to prevent the next pandemic
LANCET
IF88.5
2024-07-011
PRE
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement
2024-02-0115
OAAI
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives

团结起来战胜脂肪性肝病: 促进健康肝脏和健康生活的全球使命

2023-11-0110
PRE
A global research priority agenda to advance public health responses to fatty liver disease
2023-09-0145
OA
A global action agenda for turning the tide on fatty liver disease

扭转脂肪肝趋势的全球行动议程

2023-08-0418
OAAI
Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
2023-01-0123
OAAI
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

全球NAFLD政策审查和准备指数: 各国是否准备好应对这一无声的公共卫生挑战?

2022-04-01158
OA
A sustainable development goal framework to guide multisectoral action on NAFLD through a societal approach
2021-12-0513
OA
Advancing the global public health agenda for NAFLD: a consensus statement
2021-10-27441
OA